Hinge Health price target raised to $67 from $57 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Hinge Health (HNGE) to $67 from $57 and keeps an Overweight rating on the shares. Industry checks with Health Coaches and physical therapists confirm tech upgrades have streamlined workflows and improved member support, says the analyst, who views AI as a critical component in scaling member engagement. Rising AI effectiveness should enable growth well above the pace of operating expenses, driving margin expansion, the analyst contends.